Related references
Note: Only part of the references are listed.Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy
Man Chen et al.
LEUKEMIA & LYMPHOMA (2022)
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
Na Wang et al.
BLOOD (2020)
The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma
Xiaolu Long et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR
Yaoyao Lou et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Liquid biopsy in lymphoma: Molecular methods and clinical applications
Melita Cirillo et al.
CANCER TREATMENT REVIEWS (2020)
Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review
Javier Arzuaga-Mendez et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Melanoma circulating tumor cells: Benefits and challenges required for clinical application
G. Marsavela et al.
CANCER LETTERS (2018)
Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies
Sousuke Nakamura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
David M. Kurtz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
Elodie Bohers et al.
BLOOD CANCER JOURNAL (2018)
Application of Cell-free DNA Analysis to Cancer Treatment
Ryan B. Corcoran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
Olena Kis et al.
NATURE COMMUNICATIONS (2017)
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
A. Younes et al.
ANNALS OF ONCOLOGY (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Florian Scherer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
Jay Hocking et al.
CANCER BIOLOGY & MEDICINE (2016)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski et al.
LANCET ONCOLOGY (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Clinical Analysis and Interpretation of Cancer Genome Data
Eliezer M. Van Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Share Paper
